ASTRAZENECA
Approval Confirmed
Koselugo
Resolved
300days ago
Approval decision Β· Sep 10, 2025
What's at stake A final FDA approval decision on Koselugo for its lead indication is expected Sep 10, 2025.
β€œFDA approved Koselugo (NDA213756) β€” sponsor ASTRAZENECA; efficacy supplement (Efficacy); FDA action date 2025-09-10.”

Analyst note

NDA213756 efficacy supplement (Efficacy)

Provenance

2 sources on file.

Link copied βœ“